Morphine or Fentanyl for Refractory Dyspnea in COPD (MoreFoRCOPD)
Sponsor: Dutch Foundation for Asthma Prevention
This PHASE4 trial investigates COPD and is currently completed. Dutch Foundation for Asthma Prevention leads this study, which shows 15 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
15 versions recorded-
Jul 2025 — Present [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Sep 2024 — Jul 2025 [monthly]
Active Not Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Feb 2024 — Jul 2024 [monthly]
Recruiting PHASE4
-
Dec 2022 — Feb 2024 [monthly]
Recruiting PHASE4
▶ Show 10 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Recruiting PHASE4
-
Jun 2021 — Dec 2021 [monthly]
Recruiting PHASE4
-
Jan 2021 — Jun 2021 [monthly]
Recruiting PHASE4
-
Sep 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Jul 2020 — Sep 2020 [monthly]
Recruiting PHASE4
-
Feb 2020 — Jul 2020 [monthly]
Recruiting PHASE4
-
Dec 2019 — Feb 2020 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jun 2019 — Dec 2019 [monthly]
Not Yet Recruiting PHASE4
-
Apr 2019 — Jun 2019 [monthly]
Not Yet Recruiting PHASE4
-
Mar 2019 — Apr 2019 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Dutch Foundation for Asthma Prevention
- Huib A.M. Kerstjens
- Innovatiefonds Zorgverzekeraars
For direct contact, visit the study record on ClinicalTrials.gov .